Publication | Open Access

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer

UrologyOncologySurgical OncologyPancreatic CancerGastrointestinal OncologyGemcitabine Versus GemcitabinePhase Iii TrialMetastatic Pancreatic CancerCancer TreatmentMedicineRadiation Oncology